MLH1-silenced and non-silenced subgroups of hypermutated colorectal carcinomas have distinct mutational landscapes.
about
Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and diseaseNew therapeutic strategies for BRAF mutant colorectal cancersMicroRNAs as growth regulators, their function and biomarker status in colorectal cancerReplicative DNA polymerase mutations in cancerPilot trial of combined BRAF and EGFR inhibition in BRAF-mutant metastatic colorectal cancer patients.Hypermutation in human cancer genomes: footprints and mechanismsGermline and somatic polymerase ε and δ mutations define a new class of hypermutated colorectal and endometrial cancersNew insights into POLE and POLD1 germline mutations in familial colorectal cancer and polyposisColorectal Cancer Classification and Cell Heterogeneity: A Systems Oncology ApproachMicrosatellite instable vs stable colon carcinomas: analysis of tumour heterogeneity, inflammation and angiogenesisSomatic mutation load of estrogen receptor-positive breast tumors predicts overall survival: an analysis of genome sequence dataGastrointestinal tract cancers: Genetics, heritability and germ line mutationsGenetic predisposition to colorectal cancer: where we stand and future perspectivesMismatch repair deficiency endows tumors with a unique mutation signature and sensitivity to DNA double-strand breaks.How Can Next-Generation Sequencing (Genomics) Help Us in Treating Colorectal Cancer?Predictors of Chemosensitivity in Triple Negative Breast Cancer: An Integrated Genomic Analysis.Expression of the mismatch repair gene hMLH1 is enhanced in non-small cell lung cancer with EGFR mutationsClinicopathologic Risk Factor Distributions for MLH1 Promoter Region Methylation in CIMP-Positive Tumors.Heterozygous colon cancer-associated mutations of SAMHD1 have functional significanceDistinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway.Gene Signature in Sessile Serrated Polyps Identifies Colon Cancer Subtype.Reliable Detection of Mismatch Repair Deficiency in Colorectal Cancers Using Mutational Load in Next-Generation Sequencing Panels.Ampullary Cancers Harbor ELF3 Tumor Suppressor Gene Mutations and Exhibit Frequent WNT Dysregulation.Important molecular genetic markers of colorectal cancer.The dynamic DNA methylation landscape of the mutL homolog 1 shore is altered by MLH1-93G>A polymorphism in normal tissues and colorectal cancer.Precision medicine in colorectal cancer: evolving genomic landscape and emerging consensus.Loss of MutL Disrupts Chk2-dependent Cell Cycle Control Through CDK4/6 to Promote Intrinsic Endocrine Therapy Resistance in Primary Breast Cancer.The co-regulatory networks of tumor suppressor genes, oncogenes, and miRNAs in colorectal cancer.The therapeutic potential of targeting the BRAF mutation in patients with colorectal cancer.Morphological characterization of colorectal cancers in The Cancer Genome Atlas reveals distinct morphology-molecular associations: clinical and biological implications.MicroRNA-31 expression in relation to BRAF mutation, CpG island methylation and colorectal continuum in serrated lesions.Aberrant methylation of mutL homolog 1 is associated with increased risk of non-small cell lung cancer.Clinical Sequencing Defines the Genomic Landscape of Metastatic Colorectal Cancer.Evaluating intrinsic and non-intrinsic cancer risk factors
P2860
Q24289344-5E4D7DA8-BF85-43E6-BEE4-EE6658DC4FC7Q26772277-73BDB6B8-4881-424C-8B9E-6058916B5380Q26775610-C34EF8E3-4C13-4652-8033-C101BA4CE728Q26825747-E699EE7B-6175-4793-A387-5EB8925E4AC0Q27853121-64EBCD9B-66B5-4E4D-B068-798AECA6E966Q28255066-D57837BD-2FAA-4E6A-8669-7F259A30C8CBQ28286394-36F6F65A-499D-4603-A4DF-D9C45B400D8CQ28307340-D4DE0433-2553-4276-A38C-D35A523BEAA0Q28647615-9C055AF6-8442-4765-B921-8AF44C608C98Q30378082-EC065F2E-0F9D-48BA-A3B2-FD08F1F0A44AQ30823432-E77E6707-410F-4124-A607-B1348D93B7C4Q33599436-F729A3FC-98D4-4BFC-8037-0676403F9B79Q34008801-E722F2E0-F90A-4262-910A-000667F7D682Q34077139-5FDE9955-0714-4BEE-8EE6-0C62E77B114CQ34482529-7B2B2D22-A139-4678-897B-775AE4F6557EQ34547261-DDCA8B62-1C38-485C-AF1F-68EDBB836B91Q35036471-7E823F46-E5E1-420F-9FCB-8409FAD08744Q36463826-7657477C-7E21-49FD-B01F-9A644B1D6611Q36866147-969DD95F-90A3-42C9-8533-1DCB62D82A90Q37046544-D62F9C9E-6D73-4930-886B-AE76E6EDAC22Q37086982-760C7D84-1E93-470A-B2F0-816D628F51E7Q37130135-D1E4E0F1-28B0-4CE6-A032-DC5533F21A24Q37170296-AF2F791B-05C7-47F4-BFCC-6658913E08B8Q37619856-944C5838-DDFE-4F8F-A334-E0585BC80011Q37692625-1EBB2070-3C47-4544-B4C1-55BBD6BAEC7DQ38580566-4FA96F13-B45C-4CC5-AA7D-7CE5643B7DB7Q38628334-74240B3D-CE87-4508-9E09-F1BDDACAF462Q38694587-43798B9A-CCF7-4200-8DEF-D9A023D70ED7Q38730744-2F0B03DE-DFD8-4F44-AF50-AC41520CDD59Q38782130-DCDCE09A-32B6-4470-9EA3-03FF7E23AD95Q44981365-68FD78E8-C830-450E-884F-A963197DC416Q47807283-962A7902-854D-4F89-B6E4-82082B37BF6AQ50116991-9A5D4C7E-92F6-41E0-B91A-577D72409BA1Q58699695-A6AB15F2-AEF4-4B64-AC13-7AC322D021CD
P2860
MLH1-silenced and non-silenced subgroups of hypermutated colorectal carcinomas have distinct mutational landscapes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
MLH1-silenced and non-silenced ...... istinct mutational landscapes.
@en
MLH1-silenced and non-silenced ...... istinct mutational landscapes.
@nl
type
label
MLH1-silenced and non-silenced ...... istinct mutational landscapes.
@en
MLH1-silenced and non-silenced ...... istinct mutational landscapes.
@nl
prefLabel
MLH1-silenced and non-silenced ...... istinct mutational landscapes.
@en
MLH1-silenced and non-silenced ...... istinct mutational landscapes.
@nl
P2093
P2860
P50
P356
P1476
MLH1-silenced and non-silenced ...... istinct mutational landscapes.
@en
P2093
Chad J Creighton
Chris Sander
David Wheeler
Eve Shinbrot
Lawrence A Donehower
Preethi H Gunaratne
Richard A Gibbs
Stanley R Hamilton
P2860
P304
P356
10.1002/PATH.4087
P577
2013-01-01T00:00:00Z